Vets have until October 30 to respond to a consultation on plans by the VMD to create a new medicines category.
The VMD is proposing to introduce a new classification of drug, between POM-V and POM-VPS, that would allow clients to have repeat prescriptions for certain products for three years at a time.
The new POM-EA (extended administration) category would apply to medicines for chronic or endemic conditions only. Initial diagnosis and prescription would be made by a veterinary surgeon, who would then issue a certificate enabling the client to obtain the medicine from a pharmacist or suitably qualified person (SQP) for a period of up to 36 months.
The VMD has suggested a range of large animal medicines that could fit into the new distribution class and said the category could also be extended further to cover some small animal medicines. All but two of the suggested POM-EA products are currently classified as POM-V.
Some in the profession have raised questions about the plans, and RCVS council member Bob Partridge stated he felt the POM-EA proposal was “stupid and potentially dangerous”.
But John FitzGerald, operations director at the VMD, said the proposal would lead to more animals being treated.
For more on this story, read issue 41 of Veterinary Times, out this week. For details of the VMD’s proposal, or to issue a response to the consultation, email L.Shelley@vmd.defra.gsi.gov.uk